Clarity on disclosures in ‘Capitalization Statement’:

The Amendment Regulations provide a detailed description of the “Capitalization Statement” to be disclosed in the placement document, which was earlier unspecified in Schedule VII. Under the amended Schedule VII, the Capitalization Statement is limited to details on total borrowings, total equity, the borrowing/ equity ratios before and after the issue is made, along with the Capital Structure details.

The Amendment Regulations clarify the requirement for disclosure of a Capitalisation Statement in QIP placement documents. This requirement essentially mirrors the IPO disclosure format and, in practice, was already being included by issuers in placement documents. Accordingly, the amendment is best viewed as a clarification rather than a substantive change, and does not create new action points for issuers.

Under the amended Schedule VII, issuers are now required to disclose:

• total borrowings, total equity, and the borrowing-to-equity ratios before and after the issue; and;
• details of the capital structure, specifically authorised and subscribed capital.

This narrows the earlier market practice where issuers, in the absence of explicit guidance, would also include extensive information such as the history of equity capital raised and detailed pre- and post-issue structures — disclosures that were often duplicative and not particularly relevant for institutional investors.

That said, it is important to note that the obligation to provide a share capital build-up since incorporation continues to apply under Section 42 of the Companies Act, 2013, read with Form PAS-4. Thus, while the amendment simplifies and clarifies the disclosure requirements under ICDR Regulations, issuers will still need to comply with the corporate law requirements.

From a policy perspective, although the amendment represents progress towards simplification, a full alignment with Form PAS-4 may be necessary to truly streamline and avoid duplicative disclosures across regulatory frameworks.

Amendment in disclosure of Financial Information:

• Pre-amendment requirement:

  1. Disclosure of “Selected financial and other information.” — Issuers had to extract from (i) the audited consolidated financial statements for the last financial year (with a prior-year comparison) and (ii) the latest limited review (quarterly) results disclosed to the stock exchange (not older than six months before opening), and could also include the latest quarterly results disclosed to the public.
  2. Full financial statements for three years. Issuers had to include the audited consolidated or unconsolidated financial statements for the last three financial years, plus the latest reviewed financials; the list ran to auditors’ report, balance sheets, statements of income, cash flows, accounting policies and notes, etc.

  Post Amendment requirement:

  SEBI has pruned and clarified Schedule VII for QIPs:

  1. Capitalisation Statement: now explicitly defined (borrowings, equity and borrowings/equity ratios pre- and post-issue), prepared on consolidated numbers for the latest FY or stub period, with a note of changes post the disclosed date; capital structure now also calls out share premium (before/after).

  2. Deletion of the old “Selected financial and other information” block. (Existing clause (10) omitted.)

  3. Replacement of the three-year full pack with a concise summary: New clause (10) Financial information of the issuer requires a summary of the company’s financial position as in the three audited balance sheets immediately preceding the QIP, listing key 11 (eleven) line items (total income from operations; PBT/PAT; equity share capital; reserves; net worth; basic/diluted EPS; RoNW; NAV per share; cash flows).

Put simply, full audited financial statements and the latest quarterly pack are no longer mandated inside the QIP document.

SEBI’s stated rationale: avoid repetition, because listed issuers already file comprehensive audited financials and quarterly results under the LODR regime; QIPs are targeted to QIBs, who can fetch detailed packs from the public domain. SEBI also allowed that, where QIPs are marketed to foreign investors, issuers may add extra details to meet overseas expectations—but not as a Schedule VII mandate.

Many issuers may still voluntarily add interim (stub-period) performance snapshots or KPIs (with GAAP reconciliations) to bridge the time gap since the last audited year—especially for fast-moving businesses—mirroring past practice (see the way QIPs highlighted interim/limited-review caveats).

Amendments to ‘Business’ Sections:

Removal of management’s discussion and analysis of financial condition and results of operations’ (MD&A)

The Amendment Regulations have deleted the mandatory disclosure of the ‘management’s discussion and analysis of financial condition and results of operations’, as these details were deemed irrelevant. Such details are not mandatory disclosures for rights or preferential issue of shares either. 

MD&A is not just a descriptive section — it serves as a bridge between numbers and narrative. It explains how and why the issuer’s financial condition has evolved, providing context for revenue drivers, margin movements, liquidity, capital structure, and risk factors. In IPOs and FPOs, where the investor base includes retail and unsophisticated investors, MD&A is indispensable. It educates new investors on the business model, helps them interpret historical financials, and gives comfort on transparency.

In contrast, QIPs are restricted to QIBs — sophisticated investors with access to analyst research, company filings, management calls, and independent valuation models. For such investors, a verbose MD&A chapter largely repeats what is already disclosed in annual reports under SEBI’s LODR framework.

Listed companies in India are already obliged under Regulation 34(3) read with Schedule V of the LODR Regulations to disclose:

1. a detailed MD&A in their annual reports; and
2. risks, concerns, and mitigation strategies reviewed by the Risk Management Committee under Schedule II.

This means the market already has access to MD&A-type commentary in the public domain. Replicating it in a QIP placement document served little purpose beyond inflating document size and delaying execution.

Globally, SEBI’s approach is aligned with established practice:

1. U.S. Offerings: In SEC-registered IPOs, MD&A is a mandatory section. However, in Rule 144A / Reg S offerings to qualified institutional buyers or offshore investors, issuers typically provide audited financials and selected operating data, but do not reproduce a full MD&A unless marketing dynamics demand it. Institutional investors are assumed capable of drawing their own conclusions. 
2. Europe: In accelerated book-builds or institutional placements, offering memoranda generally include financial summaries and risk factors, but not a detailed MD&A.
3. Hong Kong / Singapore: Rights issues and placements to institutions similarly lean on existing periodic disclosures, often incorporating by reference publicly filed MD&A from annual reports.

Thus, SEBI’s rationalisation is consistent with international norms, which distinguish between retail-facing prospectuses (full MD&A) and institutional placements.

Even without a mandated MD&A, QIBs are not left unprotected:

1. They rely on the issuer’s audited three-year financial summary.
2. They can access the issuer’s LODR-mandated MD&A and risk disclosures in annual reports.
3. They typically conduct management Q&As and roadshows before subscribing to a QIP.
4. They have the benefit of analyst reports providing independent interpretation.

These mechanisms ensure that the absence of a detailed MD&A in the placement document does not compromise informed decision-making. The detailed MD&A chapter in placement documents was duplicative and added little incremental value, which is why SEBI rightly removed the mandate in September 2025.

That said, issuers may still provide supplemental narrative analysis in QIPs when material developments, recent trends, or sector volatility warrant it — ensuring investors have both transparency and timeliness.

Business and Industry Description – Shift to a Summary Format

The Amendment Regulations substitute the earlier requirement of detailed “Business” and “Industry” descriptions in QIP placement documents with a single consolidated clause:

“Business and Industry description: A summary of the primary business of the issuer and the industry in which it operates.”

This significantly reduces the length and depth of disclosures that were previously expected under Schedule VII.

Traditionally, placement documents for QIPs mirrored IPO-style offer documents, which included:

1. a detailed “Industry Overview” section (macro-economic trends, sector growth, regulatory framework, peer comparisons, risks and opportunities); and
2. a comprehensive “Business” section (brief overview comprising history, promoters, subsidiaries, manufacturing facilities, product/service lines, strategy, strengths, intellectual property, competition, customers, suppliers, regulatory matters, etc.).

In practice, QIP placement documents often reproduced large extracts from the issuer’s IPO prospectus or annual report, supplemented with management presentations. The stated justification was that the business section not only informed investors but also served to “market the issue” by showcasing the issuer’s strengths.

Rationale for Change

SEBI’s consultation paper and amendments highlight three key reasons for rationalising:

Listed company context – QIP issuers are already listed and subject to continuous disclosure obligations under the LODR Regulations. Their business model, strategies, and industry environment are well-known to the market and readily accessible in public filings.

Investor profile – QIPs are offered only to QIBs, who are sophisticated investors with access to analyst coverage, independent research, and management briefings. They do not require extensive background reading within the placement document.

Avoiding duplication – Reproducing detailed business and industry sections delays documentation and results in excessive repetition of information already available in annual reports, investor presentations, and stock exchange filings.

Despite the regulatory relaxation, there are practical reasons issuers may still choose to include some level of detail:

1. Marketing the issue: The “Business” section of a placement document also functions as a selling document. Even institutional investors expect a coherent, well-articulated narrative of the issuer’s strategy, strengths, and competitive positioning. Cutting back too much may weaken the marketing impact.

2. Consistency with investor communications: Any statements made in investor presentations or roadshows must be aligned with disclosures in the placement document. If management presents detailed growth strategies, customer additions, or industry tailwinds during roadshows, omitting them from the placement document could expose the issuer to liability risks and questions of selective disclosure.

The amendment clearly eases the compliance burden by permitting only a summary of business and industry in QIP documents. However, from a practical and legal risk-management perspective:

1. Issuers may still prefer to include a reasonably elaborated summary, particularly of their business strategy, strengths, and market position.
2. At a minimum, disclosures in the placement document must align with any claims or projections made in investor presentations or roadshows, to avoid inconsistencies or allegations of misrepresentation.
3. Over time, market practice may converge on a middle ground: shorter than IPO-style narratives, but still robust enough to market the issue and serve as a defensible disclosure record.

Amendment to ‘Board of Directors and Senior Management’ Section:

Pursuant to the Amendment Regulations, SEBI has clarified that only limited details of directors and senior management are required to be disclosed in QIP placement documents.

These include:

1. name,
2. date of birth,
3. age,
4. Director Identification Number (DIN),
5. address,
6. occupation, and
7. date of expiration of the current term of office.

No Requirement for Detailed Profiles – Unlike IPO offer documents, there is no mandatory requirement in QIPs to provide elaborate biographical profiles of directors or senior management, such as their educational qualifications, past work experience, or professional achievements.

Outstanding Litigation Disclosures – From Flexibility to Uniformity (Yet with ambiguity on thresholds approach)

Prior to the Amendment Regulations, disclosure of outstanding litigation in QIP placement documents under Schedule VII was linked to the issuer’s board-approved materiality policy framed under Regulation 30 of the LODR Regulations.

In practice, QIP placement documents exhibited wide divergence:

1. All criminal and regulatory proceedings were generally disclosed irrespective of amount.

2. Civil, arbitration, and tax matters were disclosed only if they crossed thresholds as set out under the LODR Regulations.

3. Non-quantifiable matters were included if they could potentially have a material adverse effect.

4. Pre-litigation notices were usually excluded.

This issuer-by-issuer tailoring, while legally permissible, created inconsistency and uncertainty for investors.

Pursuant to the Amendment Regulations, the issuers are required to disclose:

• Summary tabular disclosure of all pending matters that, if decided adversely, would materially and adversely affect the issuer’s operations or financial position.

• Mandatory inclusion, irrespective of thresholds, of:

  1. criminal liability proceedings,

  2. material statutory violations, and
  3. economic offences against the issuer.

• Uniform materiality tests, defined as the lower of:

  1. the thresholds in the issuer’s materiality policy, or
  2. bright-line thresholds (2% of turnover; 2% of net worth; or 5% of average absolute PAT over three years).

These bright-line tests are identical to those already prescribed under Regulation 30 of the LODR Regulations for ongoing disclosure of material events, thereby harmonising continuous disclosure prescribed under Regulation 30 of the LODR Regulations with fundraising disclosure.

Ambiguity in Uniformity

While the Amendment Regulations were introduced with the stated intent of harmonising disclosures in QIP placement documents with those already available in the public domain, an important inconsistency has emerged.

Under the SEBI ISF Circular of February 25, 2025, listed entities are required to apply only two bright-line parameters for determining materiality of pending litigations under Regulation 30 of the LODR Regulations: 2% of consolidated turnover, or 5% of average PAT.

The net worth parameter was consciously excluded by the Industry Standards Forum (ISF) to simplify and standardise disclosures.

However, the Amendment Regulations continue to retain the 2% of net worth test (alongside turnover and PAT) for litigation disclosures in QIP placement documents. This results in a clear divergence: a litigation may be considered immaterial for ongoing disclosure under LODR (per ISF) but still require disclosure in a QIP placement document (per ICDR).

This disparity undermines the very principle of parity between periodic disclosures and fundraising disclosures that SEBI sought to achieve. Instead of uniformity, issuers now face dual disclosure standards: one under the LODR framework (as modified by ISF) and another under ICDR.

The ambiguity does not stop with QIPs. Since the same thresholds apply to rights issues, the inconsistency also affects issuances aimed at the retail market, where uniformity is even more critical.

Unless SEBI takes steps to reconcile the ISF standards with the ICDR thresholds, issuers will be left with no option but to over-disclose in offer documents to mitigate liability risks, thereby defeating the purpose of the rationalisation exercise.

Other Salient Changes

The definition of a QIB under Regulation 2(1)(ss) has been broadened to include accredited investors as defined under SEBI (Alternative Investment Funds) Regulations, 2012, as amended (“AIF Regulations”). SEBI, through its recent amendment to the ICDR Regulations, has introduced a new category under the definition provisions. The change recognizes “accredited investors” as defined under Regulation 2(1)(ab) of the AIF Regulations, but only for the limited purpose of their investment in Angel Funds registered with SEBI. This amendment essentially aligns the ICDR framework with the AIF Regulations, ensuring consistency in the treatment of accredited investors across regulatory regimes. By doing so, SEBI has clarified that accredited investors, who already meet prescribed eligibility criteria relating to financial capacity and sophistication, may participate in Angel Funds within the regulated ambit of AIFs. However, the recognition is narrowly tailored — it does not extend to other forms of investment under the ICDR Regulations, but only to Angel Fund participation.

Conclusion

The Amendment Regulations underscore SEBI’s progressive evolution in disclosure philosophy. By pruning certain sections of Schedule VII — such as risk factors (restricted to issuer- and issue-specific), financial statements (condensed to key audited summaries), and litigation (codified thresholds with mandatory categories) — SEBI has signalled a decisive move towards harmonisation with the LODR Regulations and a recognition that QIBs require precision, not repetition. This reflects a global best practice approach: tailoring disclosure norms to the sophistication of the investor base.

Yet, a deeper reading of Schedule VII against actual practice in QIP documents reveals the limits of this rationalisation. Several expansive sections remain untouched despite being equally duplicative. For instance, detailed shareholding patterns and organisational charts, already disclosed under the LODR Regulations, Market Price Information, Related Party Transactions and Dividends (already disclosed in financials).

The result is a halfway harmonisation: while SEBI has commendably eliminated obvious duplication (such as quarterly financials and external risk factors), it has left intact other sections whose informational value to QIBs is marginal.

Further, the litigation disclosure framework illustrates an ambiguity in uniformity. SEBI has hard-wired into Schedule VII the bright-line thresholds of 2% turnover, 2% net worth, and 5% PAT — directly borrowing from Regulation 30 of the LODR Regulations — but this sits uneasily with the SEBI ISF Circular of February 2025, which consciously removed the net worth test and prescribed only turnover and PAT as relevant parameters. The effect is that a litigation may be considered immaterial for ongoing LODR disclosures yet still require disclosure in a placement document. This divergence not only undermines SEBI’s stated goal of ensuring parity between public domain information and fundraising documents but also extends beyond QIPs to rights issues.

Thus, while the amendments reflect SEBI’s progressive spirit — moving from exhaustive, IPO-style templates to concise, contextual disclosures — they also expose the transitional character of the reform. Until SEBI revisits Schedule VII holistically and reconciles divergences, issuers will continue to operate under a regime that is leaner than before, yet not as lean or uniform as it could be.